Shellong Trial

The Schellong test is a test that is used to assess blood glucose levels. It was developed by German physician Otto Schellong in 1921.

The Shellong test is carried out as follows: the patient is injected intravenously with a glucose solution, after which the blood glucose level is measured at certain intervals. If glucose levels rise, this indicates that the pancreas is working normally and producing enough insulin. If the glucose level does not increase or decreases, this may indicate a malfunction of the pancreas or the presence of diabetes mellitus.

This test is widely used in medicine for the diagnosis and treatment of diabetes and other diseases associated with metabolic disorders. It can also be used to monitor the effectiveness of diabetes treatment in patients already taking insulin.

However, like any other test, the Shellong test has its limitations and may not always give an accurate result. Therefore, to obtain more accurate information about the patient’s health status, it is necessary to use a set of diagnostic methods, including blood tests, urine tests, and other research methods.